📣 VC round data is live. Check it out!
- Public Comps
- Sanara MedTech
Sanara MedTech Valuation Multiples
Discover Sanara MedTech's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Lucid Diagnostics, Anika Therapeutics, Medinice, Asterasys and more.
Sanara MedTech Overview
About Sanara MedTech
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Founded
2001
HQ

Employees
141
Website
Financials (LTM)
EV
$231M
Valuation Multiples
Start free trialSanara MedTech Financials
Sanara MedTech reported last 12-month revenue of $109M and EBITDA of $17M.
In the same LTM period, Sanara MedTech generated $101M in gross profit, $17M in EBITDA, and had net loss of ($21M).
Revenue (LTM)
Sanara MedTech P&L
In the most recent fiscal year, Sanara MedTech reported revenue of $103M and EBITDA of $17M.
Sanara MedTech is unprofitable as of last fiscal year, with gross margin of 93%, EBITDA margin of 16%, and net margin of (36%).
Financial data powered by Morningstar, Inc.
Sanara MedTech Stock Performance
Sanara MedTech has current market cap of $196M, and enterprise value of $231M.
Market Cap Evolution
Sanara MedTech's stock price is $21.36.
Sanara MedTech share price decreased by 6.3% in the last 30 days, and by 24.6% in the last year.
Sanara MedTech has an EPS (earnings per share) of $-4.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $231M | $196M | -2.6% | -6.3% | 24.3% | -24.6% | $-4.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSanara MedTech Valuation Multiples
Sanara MedTech trades at 2.1x EV/Revenue multiple, and 13.7x EV/EBITDA.
EV / Revenue (LTM)
Sanara MedTech Financial Valuation Multiples
As of June 3, 2026, Sanara MedTech has market cap of $196M and EV of $231M.
Sanara MedTech has a P/E ratio of (9.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sanara MedTech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Sanara MedTech Margins & Growth Rates
Sanara MedTech grew revenue by 14% but EBITDA decreased by 2% in the last fiscal year.
In the most recent fiscal year, Sanara MedTech reported gross margin of 93%, EBITDA margin of 16%, and net margin of (36%).
Sanara MedTech Margins
Sanara MedTech Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Sanara MedTech Operational KPIs
Sanara MedTech's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.6M for the same period.
Sanara MedTech's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sanara MedTech's Rule of X is 50% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Sanara MedTech Competitors
Sanara MedTech competitors include Lucid Diagnostics, Anika Therapeutics, Medinice, Asterasys, Ilex Medical, RxSight, TriSalus Life Sciences, Surgical Science, Deltex Medical Group and InfuSystem.
Most Sanara MedTech public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 44.1x | 35.6x | (3.7x) | (4.0x) | |||
| 1.6x | 1.5x | 33.0x | 24.0x | |||
| - | - | (111.9x) | - | |||
| 7.5x | 6.3x | 22.7x | 18.2x | |||
| 0.4x | - | 3.3x | - | |||
| (0.0x) | (0.0x) | 0.1x | 0.0x | |||
| 4.0x | 3.7x | (11.1x) | (12.2x) | |||
| 1.0x | 1.0x | 5.6x | 6.1x | |||
This data is available for Pro users. Sign up to see all Sanara MedTech competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Sanara MedTech
Sanara MedTech has acquired 2 companies to date.
Last acquisition by Sanara MedTech was on July 1st 2022. Sanara MedTech acquired Scendia Biologics for $7M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Sanara MedTech
| Description | Scendia Biologics supplies orthobiologics and soft tissue repair products for various surgical procedures. | Precision Healing is a medical technology company providing wound healing assessment tools. San Francisco-headquartered, it deploys AI-powered imaging platforms to evaluate wound state and predict healing trajectories for clinicians. The system analyzes tissue composition, infection risk, and perfusion data from standard smartphone cameras, supporting chronic wound management in hospitals and outpatient clinics across the United States. |
| HQ Country | ||
| HQ City | Orlando, FL | Boston, MA |
| Deal Date | 1 Jul 2022 | 4 Apr 2022 |
| Valuation | $7M | $8M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Sanara MedTech acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by Sanara MedTech
Sanara MedTech has invested in 1 company to date.
Latest investment by Sanara MedTech was on January 21st 2025. Sanara MedTech invested in Biomimetic Innovations in their $4M Strategic investment round (EV/Revenue multiple available to Pro users).
Latest Investments by Sanara MedTech
| Description | Biomimetic Innovations is a medical device company commercializing synthetic biomaterials for tissue repair. Through pbcbiomed.com, the firm advances regenerative technologies targeting orthopedic, dental, and wound healing applications with scaffold materials that promote natural healing processes. |
| HQ Country | |
| HQ City | Shannon |
| Deal Date | 21 Jan 2025 |
| Round | Strategic investment |
| Raised | $4M |
| Investors | Sanara MedTech |
| Valuation | $74M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Sanara MedTech investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sanara MedTech
| When was Sanara MedTech founded? | Sanara MedTech was founded in 2001. |
| Where is Sanara MedTech headquartered? | Sanara MedTech is headquartered in United States. |
| How many employees does Sanara MedTech have? | As of today, Sanara MedTech has over 141 employees. |
| Who is the CEO of Sanara MedTech? | Sanara MedTech's CEO is Seth D. Yon. |
| Is Sanara MedTech publicly listed? | Yes, Sanara MedTech is a public company listed on Nasdaq. |
| What is the stock symbol of Sanara MedTech? | Sanara MedTech trades under SMTI ticker. |
| When did Sanara MedTech go public? | Sanara MedTech went public in 2020. |
| Who are competitors of Sanara MedTech? | Sanara MedTech main competitors include Lucid Diagnostics, Anika Therapeutics, Medinice, Asterasys, Ilex Medical, RxSight, TriSalus Life Sciences, Surgical Science, Deltex Medical Group, InfuSystem. |
| What is the current market cap of Sanara MedTech? | Sanara MedTech's current market cap is $196M. |
| What is the current revenue of Sanara MedTech? | Sanara MedTech's last 12 months revenue is $109M. |
| What is the current revenue growth of Sanara MedTech? | Sanara MedTech revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Sanara MedTech? | Current revenue multiple of Sanara MedTech is 2.1x. |
| What is the current EBITDA of Sanara MedTech? | Sanara MedTech's last 12 months EBITDA is $17M. |
| What is Sanara MedTech's EBITDA margin? | Sanara MedTech's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Sanara MedTech? | Current EBITDA multiple of Sanara MedTech is 13.7x. |
| How many companies Sanara MedTech has acquired to date? | As of June 2026, Sanara MedTech has acquired 2 companies. |
| What was the largest acquisition by Sanara MedTech? | $8M acquisition of Precision Healing on 4th April 2022 was the largest M&A Sanara MedTech has done to date. |
| What companies Sanara MedTech acquired? | Sanara MedTech acquired Precision Healing and Scendia Biologics. |
| In how many companies Sanara MedTech has invested to date? | As of June 2026, Sanara MedTech has invested in 1 company. |
| What was the last Sanara MedTech investment? | On 21st January 2025 Sanara MedTech invested in Biomimetic Innovations, participating in a $4M Strategic investment round at $74M valuation. |
| In what companies Sanara MedTech invested in? | Sanara MedTech invested in Biomimetic Innovations. |
See public comps similar to Sanara MedTech
Lists including Sanara MedTech
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

